Inhalable microparticles modify cytokine secretion by lung macrophages of infected mice

Tuberculosis

Volumn 91, Issue 1, 2011, Pages 107-110

  Sharma, Rolee ^b   Yadav, Awadh Bihari ^c   Muttil, Pavan ^d   Kajal, Heikham ^a   Misra, Amit ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b UNIVERSITY OF LUCKNOW   (India)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Cytokines; Innate immune response; Microspheres; Pulmonary drug delivery; Tuberculosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; ISONIAZID; RIFABUTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFICACY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

ADMINISTRATION, INHALATION; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; ISONIAZID; MACROPHAGES, ALVEOLAR; MALE; MYCOBACTERIUM TUBERCULOSIS; RIFABUTIN; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79551488013     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2010.11.003     Document Type: Article

References (25)

1. J. Wang, J. Wakeham, R. Harkness, and Z. Xing Macrophages are a significant source of type 1 cytokines during mycobacterial infection J Clin Invest 103 1999 1023 1029
2. J. Flynn, and B. Bloom Role of T1 and T2 cytokines in the response to Mycobacterium tuberculosis Ann N Y Acad Sci 795 1996 137 146
3. S. Fulton, J. Cross, Z. Toossi, and W. Boom Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra J Infect Dis 178 1998 1105 1114
4. B. Chiu, C. Freeman, V. Stolberg, E. Komuniecki, P. Lincoln, and S. Kunkel Cytokine-chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formation Am J Respir Cell Mol Biol 29 2003 106 116
5. P. Murray, L. Wang, C. Onufryk, R. Tepper, and R. Young T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection J Immunol 158 1997 315 321
6. S. Redpath, P. Ghazal, and N. Gascoigne Hijacking and exploitation of IL-10 by intracellular pathogens Trends Microbiol 9 2001 86 92
7. F.C.M. Ameglio, E. Capoluongo, P. Mattia, G. Puglisi, and S. Giosue Post-treatment changes of sIU cytokines in active pulmonary tuberculosis: differences between patients with stable or increased fibrosis Int J Tuberc Lung Dis 9 2005 98 104
8. S. Suarez, P. O'Hara, M. Kazantseva, C.E. Newcomer, R. Hopfer, and D.N. McMurray Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model Pharm Res 18 2001 1315 1319
9. S. Suarez, P. O'Hara, M. Kazantseva, C.E. Newcomer, R. Hopfer, and D.N. McMurray Airways delivery of rifampicin microparticles for the treatment of tuberculosis J Antimicrob Chemother 48 2001 431 434
10. R. Pandey, and G.K. Khuller Antitubercular inhaled therapy: opportunities, progress and challenges J Antimicrob Chemother 55 2005 430 435
11. R. Pandey, and G.K. Khuller Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis Tuberculosis (Edinb) 85 2005 227 234
12. H. Sen, S. Jayanthi, R. Sinha, R. Sharma, and P. Muttil Inhalable biodegradable microparticles for target-specific drug delivery in tuberculosis and a process thereof PCT Int Pat Appl 2003 PCT/IB 03/04694
13. J. Kaur, P. Muttil, R.K. Verma, K. Kumar, A.B. Yadav, and R. Sharma A hand-held apparatus for "nose-only" exposure of mice to inhalable microparticles as a dry powder inhalation targeting lung and airway macrophages Eur J Pharm Sci 34 2008 56 65
14. M.H. Cynamon, Y. Zhang, T. Harpster, S. Cheng, and M.S. DeStefano High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infection Antimicrob Agents Chemother 43 1999 2922 2924
15. Y. Shibata, L.A. Foster, W.J. Metzger, and Q.N. Myrvik Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice Infect Immun 65 1997 1734 1741
16. S. Prior, B. Gander, N. Blarer, H. Merkle, M. Subira, and J. Irache In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-coglycolide) microspheres Eur J Pharm Sci 15 2002 197 207
17. I. Gonda Targeting by deposition A. Hickey, Pharmaceutical inhalation aerosol technology 2nd ed. 2004 Marcel Dekker New York 65 88
18. A. Blumenthal, J. Lauber, R. Hoffmann, M. Ernst, C. Keller, and J. Buer Common and unique gene expression signatures of human macrophages in response to four strains of Mycobacterium avium that differ in their growth and persistence characteristics Infect Immun 73 2005 3330 3341
19. C.B. Pereira, M. Palaci, O.H. Leite, A.J. Duarte, and G. Benard Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations Microbes Infect 6 2004 25 33
20. C. Keller, J. Lauber, A. Blumenthal, J. Buer, and S. Ehlers Resistance and susceptibility to tuberculosis analysed at the transcriptome level: lessons from mouse macrophages Tuberculosis (Edinb) 84 2004 144 158
21. D. Gil, L.F. Garcia, and M. Rojas Modulation of macrophage apoptosis by antimycobacterial therapy: physiological role of apoptosis in the control of Mycobacterium tuberculosis Toxicol Appl Pharmacol 190 2003 111 119
22. E. Kim, S.H. Kim, S. Kim, and T.S. Kim The novel cytokine p43 induces IL-12 production in macrophages via NF-kappaB activation, leading to enhanced IFN-gamma production in CD4+ T cells J Immunol 176 2006 256 264
23. J.L. Flynn, J. Chan, K.J. Triebold, D.K. Dalton, T.A. Stewart, and B.R. Bloom An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection J Exp Med 178 1993 2249 2254
24. B.M. Saunders, H. Briscoe, and W.J. Britton T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection Clin Exp Immunol 137 2004 279 287
25. K.G. Veenstra, Z.L. Jonak, S. Trulli, and J.A. Gollob IL-12 induces monocyte IL-18 binding protein expression via IFN-gamma J Immunol 168 2002 2282 2287